CompoAtlas

VITAVADA - BRULE GRAISSE EXTRA FORT - INTERIEUR

Food supplement declared in France, declaration No 2023-11-470

VITAVADA - BRULE GRAISSE EXTRA FORT - INTERIEUR, from BELLE & BIO (BELLE & BIO), is a food supplement declared in France. Status: withdrawal from the market announced for 9 February 2027. Main ingredients: Withania somnifera 126 mg per day, Opuntia ficus-indica 100 mg per day, Betula pendula 74 mg per day, Cola nitida 40 mg per day, Cichorium intybus 20 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
BELLE & BIO (BELLE & BIO)
Status
Withdrawal from the market announced for 9 February 2027
Form
Capsule
Daily dose
2 gélules et 2 gélules
Directions for use
prendre 2 gélules le matin et 2 gélules le soir
Intended populations
Men, Women
Not recommended (according to the manufacturer)
Taking anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Slimming / Fat burner

Declaration 305936, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Withania somnifera (L.) DunalRacineExtrait sec hydroalcoolique126 mg
Opuntia ficus-indica (L.) Mill.FeuillePoudre (de plantes séchées ou broyées)100 mg
Betula pendula RothFeuillePoudre (de plantes séchées ou broyées)74 mg
Cola nitida (Vent.) Schott et Endl.GrainePoudre (de plantes séchées ou broyées)40 mg
Cichorium intybus L.RacinePoudre (de plantes séchées ou broyées)20 mg

Other active ingredients

NamePer day
Tyrosinenot declared
Inulinenot declared
L-Carnitine L-Tartratenot declared
Théaninenot declared
L-Glutaminenot declared
Citrullinenot declared

Additives

E460, E470b

Other ingredients

Acacia seyal Delile, gélatine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux personnes souffrant d'allergie aux dérivés salicylés d’intolérance aux anti-inflammatoires non-stéroïdiens. Déconseillé aux enfants de moins de 12 ans, femmes enceintes ou allaitantes. contient de la caféine (0,8mg/jours)

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Withania somnifera (L.) Dunal
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    Sources cited by Health Canada (3)
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    Sources cited by Health Canada (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
    • Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.

    Health Canada monograph dated 28 February 2025

  • Betula pendula Roth
    Read the warning, when it applies and the studies cited

    Birch

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).

    Sources cited by Health Canada (4)
    • Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Health Canada monograph dated 28 August 2024

  • Tyrosine
    Read the warning, when it applies and the studies cited

    L-TYROSINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 30 January 2026

  • Théanine
    Read the warning, when it applies and the studies cited
  • L-Glutamine
    Read the warning, when it applies and the studies cited

    L-Glutamine

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “VITAVADA - BRULE GRAISSE EXTRA FORT - INTERIEUR: composition and regulation”, https://compoatlas.com/en/supplements/products/305936-vitavada-brule-graisse-extra-fort-interieur, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line